Literature DB >> 12234838

Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals.

Laura Briñas1, Myriam Zarazaga, Yolanda Sáenz, Fernanda Ruiz-Larrea, Carmen Torres.   

Abstract

TEM-, SHV-, and OXA-type beta-lactamases were studied by PCR with 124 ampicillin-resistant (AMP(r)) Escherichia coli isolates recovered from foods of animal origin (n = 20) and feces of humans (n = 49) and healthy animals (n = 55). PCR showed that 103 isolates were positive for TEM and negative for SHV and OXA. Three E. coli isolates showed a positive reaction for OXA, and one showed a positive reaction for SHV. The remaining 17 E. coli isolates were negative for the three enzymes by PCR. Fifty-seven of the 103 bla(TEM) amplicons were sequenced. Different molecular variants of bla(TEM-1) were found in 52 isolates: bla(TEM-1a) (n = 9), bla(TEM-1b) (n = 36), bla(TEM-1c) (n = 6), and bla(TEM-1f) (n = 1). Four inhibitor-resistant TEM (IRT) beta-lactamase-encoding genes were also detected: bla(TEM-30c) (IRT-2), bla(TEM-34b) (IRT-6), bla(TEM-40b) (IRT-11), and bla(TEM-51a) (IRT-15). A new bla(TEM) gene, named bla(TEM-95b), which showed a mutation in amino acid 145 (P-->A) was detected. It was found in a food isolate of chicken origin (AMP(r), amoxicillin-clavulanic acid susceptible). The promoter region in 24 bla(TEM) amplicons was analyzed, and the weak P3 promoter was found in 23 of them (bla(TEM-1) in 20 amplicons and bla(TEM-51a), bla(TEM-30c), and bla(TEM-95b) in 1 amplicon each). The strong Pa/Pb promoter was found only in the bla(TEM-34b) gene. No extended-spectrum beta-lactamases were detected. Mutations at position -42 or -32 in the ampC gene promoter were demonstrated in 4 of 10 E. coli isolates for which the cefoxitin MIC was >/=16 micro g/ml. Different variants of bla(TEM-1) and IRT bla(TEM) genes were found among the AMP(r) E. coli isolates from foods and the feces of humans and healthy animals, and a new gene, bla(TEM-95b) (P3), was detected.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234838      PMCID: PMC128764          DOI: 10.1128/AAC.46.10.3156-3163.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

1.  Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production.

Authors:  N Caroff; E Espaze; I Bérard; H Richet; A Reynaud
Journal:  FEMS Microbiol Lett       Date:  1999-04-15       Impact factor: 2.742

Review 2.  Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.

Authors:  E B Chaïbi; D Sirot; G Paul; R Labia
Journal:  J Antimicrob Chemother       Date:  1999-04       Impact factor: 5.790

3.  Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.

Authors:  Constança Féria; Eugénia Ferreira; José Duarte Correia; José Gonçalves; Manuela Caniça
Journal:  J Antimicrob Chemother       Date:  2002-01       Impact factor: 5.790

4.  Updated sequence information for TEM beta-lactamase genes.

Authors:  S Goussard; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

5.  Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.

Authors:  J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

Review 6.  Inhibitor resistant class A beta-lactamases.

Authors:  R A Bonomo; L B Rice
Journal:  Front Biosci       Date:  1999-05-15

7.  Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli.

Authors:  E C Nelson; B G Elisha
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 8.  Beta-lactamase-mediated resistance and opportunities for its control.

Authors:  D M Livermore
Journal:  J Antimicrob Chemother       Date:  1998-06       Impact factor: 5.790

9.  Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.

Authors:  G Vedel; A Belaaouaj; L Gilly; R Labia; A Philippon; P Névot; G Paul
Journal:  J Antimicrob Chemother       Date:  1992-10       Impact factor: 5.790

10.  Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase.

Authors:  M Gazouli; L S Tzouvelekis; A C Vatopoulos; E Tzelepi
Journal:  J Antimicrob Chemother       Date:  1998-10       Impact factor: 5.790

View more
  75 in total

1.  Detection of CMY-2, CTX-M-14, and SHV-12 beta-lactamases in Escherichia coli fecal-sample isolates from healthy chickens.

Authors:  Laura Briñas; Miguel Angel Moreno; Myriam Zarazaga; Concepción Porrero; Yolanda Sáenz; María García; Lucas Dominguez; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

2.  Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain.

Authors:  Aránzazu Valverde; Teresa M Coque; M Paz Sánchez-Moreno; Azucena Rollán; Fernando Baquero; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

3.  New integron-associated gene cassette encoding a 3-N-aminoglycoside acetyltransferase.

Authors:  Renee S Levings; Sally R Partridge; Diane Lightfoot; Ruth M Hall; Steven P Djordjevic
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals.

Authors:  Michael R Mulvey; Elizabeth Bryce; David A Boyd; Marianna Ofner-Agostini; Allison M Land; Andrew E Simor; Shirley Paton
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Multiple antimicrobial resistance of gram-negative bacteria from natural oligotrophic lakes under distinct anthropogenic influence in a tropical region.

Authors:  D S Pontes; F A Pinheiro; C I Lima-Bittencourt; R L M Guedes; L Cursino; F Barbosa; F R Santos; E Chartone-Souza; A M A Nascimento
Journal:  Microb Ecol       Date:  2009-06-06       Impact factor: 4.552

6.  Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011.

Authors:  D Bhattacharya; H Bhattacharya; R Thamizhmani; D S Sayi; R Reesu; M Anwesh; C Kartick; A P Bharadwaj; M Singhania; A P Sugunan; S Roy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-29       Impact factor: 3.267

7.  First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States.

Authors:  Alexandra O'Keefe; Tabitha A Hutton; Dieter M Schifferli; Shelley C Rankin
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

8.  Role of TEM-1 β-Lactamase in the Predominance of Ampicillin-Sulbactam-Nonsusceptible Escherichia coli in Japan.

Authors:  Taro Noguchi; Yasufumi Matsumura; Toru Kanahashi; Michio Tanaka; Yasuhiro Tsuchido; Takuro Matsumura; Satoshi Nakano; Masaki Yamamoto; Miki Nagao; Satoshi Ichiyama
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

9.  Antimicrobial resistance in equine faecal Escherichia coli isolates from North West England.

Authors:  Mohamed O Ahmed; Peter D Clegg; Nicola J Williams; Keith E Baptiste; Malcolm Bennett
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-04-07       Impact factor: 3.944

10.  High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar.

Authors:  Todisoa Andriatahina; Frédérique Randrianirina; Eliosa Ratsima Hariniana; Antoine Talarmin; Honoré Raobijaona; Yves Buisson; Vincent Richard
Journal:  BMC Infect Dis       Date:  2010-07-12       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.